Whoa! What Just Happened With My Stock?

The Dow Jones Industrial Average (INDEX: ^DJI  ) jumped 1.4% on Friday, rising 173 points as retailers kicked off the official start of the holiday shopping season. But with global financial and economic concerns still an ever-present threat, no doubt the gains will be short-lived.

Yet while I expect the exuberance will be fleeting and we'll see greater volatility in the markets, some stocks even rose by double-digit percentages.


% Gain

Molycorp (NYSE: MCP  )


Research In Motion (Nasdaq: RIMM  )


Star Scientific (Nasdaq: STSI  )


Yet resist the urge to high-five everyone in the cubicles next to you. Smart investors won't celebrate until they know why their stock surged, because without a fundamental basis for the bounce, these stocks could just as quickly make the return trip down.

No news is good news
"Truth is so rare that it is delightful to tell it," or so wrote Emily Dickinson. Obviously, the market hasn't taken my advice to avoid rare-earths mineral miner Molycorp, because it has been less than forthright with investors about SEC investigations into the accuracy of its public disclosures. While that's rarely something you want to buy into, Molycorp's stock has soared almost 40% since I penned that missive, as insiders including the company's CEO have bought tens of thousands of shares of the depressed stock.

Insider buying is often a bullish sentiment, but there are still lingering doubts about the company's financial wherewithal and the way the SEC investigation will play out. Although the market's ignored my advice, I think I'll be proved right in the end, so I'll rate Molycorp to underperform the markets on Motley Fool CAPS, the 180,000 member-driven investor community that translates informed opinion into stock ratings of one to five stars.

Tell me in the comments section below if you agree that Molycorp's outperformance is as rare as hen's teeth.

Another company rubbing my nose in an underperform rating is Research In Motion, which has been rising based on hopes that its new BlackBerry 10 operating system will prove to be the lever that throws sales into high gear again.

Nokia (NYSE: NOK  ) has garnered positive reviews for its new Lumia 920, suggesting that there is pent up-demand for a phone that will break the hegemony of Apple's (Nasdaq: AAPL  ) iOS and Google's (Nasdaq: GOOG  ) Android platform, and analysts suggest that carriers such as Verizon (NYSE: VZ  ) and AT&T (NYSE: T  ) want to break their stranglehold.

Yet theory and practice are two different things, and despite some hints that BB10 will be at least as good as iOS and Android, until it's in the marketplace we won't know -- and that's still a few months away. In the meantime, analysts are now simply trying to outdo one another with how upbeat they can sound about the tidal wave of change RIM will wreak on the market. One analyst calls for a price target of more than $40 a share, while another upped his estimates of phone sales to 35.5 million from 31.6 million ... all for something not even on the market yet!

This wall of euphoria seems ripe for tumbling down, so I'll be leaving my underperform rating on CAPS in place. It's currently losing to the indexes, as the stock has soared 55% since I weighed in on Research In Motion in August, compared with the S&P 500's 2% fall, but there seems too much riding on hope. Let me know below if you plan on upgrading your phone -- BlackBerry or otherwise -- to the new system in 2013.

Exercising discretion
Supplements maker Star Scientific continued the run higher it began more than one week ago, when it reported a financing deal that had the CEO and other large investors putting $20 million into the company through the exercise of warrants. The stock has moved higher by some 66%, as investors ignored the warning that the arrangement actually caused Star to leave a lot of money on the table in the process.

As it moves away from tobacco products and focuses on its Anabloc dietary supplement, perhaps they think this will still give the company sufficient capital to overcome short-term doubts about its viability and allow it to continue growing in the future. I'm not so certain about that, so after yet another day of running higher, I'll be rating Star Scientific to underperform the broad indexes on CAPS. Let me know, though, whether you think Star will smoke out the naysayers.

Whoa, Nelly!
There is absolutely no argument that Apple is at the center of technology's largest revolution ever, and that longtime shareholders have been handsomely rewarded with over 1,000% gains. However, there is a debate raging as to whether Apple remains a buy. The Motley Fool's senior technology analyst and managing bureau chief, Eric Bleeker, is prepared to fill you in on both reasons to buy and reasons to sell Apple, and what opportunities are left for the company (and more importantly, your portfolio) going forward. To get instant access to his latest thinking on Apple, simply click here now.

Read/Post Comments (3) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On November 26, 2012, at 11:57 PM, mirra88888 wrote:

    I can't wait for BB10. I used to use Blackberry and switched to iphone last year. They lost all my contacts on the cloud and my phone keeps on freezing.I have been researching the new bb10 and must say that I am very impressed. I cannot wait to get rid of my iphone when bb10 comes out.

  • Report this Comment On November 27, 2012, at 5:50 AM, infektu wrote:

    You say that there seems too much riding on hope... maybe, but there was waay more riding on the doom.

    At 7 bucks RIM was priced 65% below liquidation.

    They don't need to sell a gabazillion devices, don't need to outsell Samsung or Apple (although one day that might also be possible).

    All they need to do is give the people that want a BlackBerry a better BlackBerry.

    A large proportion of the 80M are waiting, and the BB is a better BB, for sure.

    There will be dips below $11, but in general good luck with your underperform rating.

  • Report this Comment On November 27, 2012, at 8:40 PM, digitally404 wrote:

    The OS timeline:

    iOS (Jan. 2007) --> 6 years old

    Android (Feb. 2009) --> 4 years old

    BB10 (Jan. 2013)

    Considering BB10 is the most stable platform built on an OS used to power shuttles, power plants, and cars, and that it will be the newest OS, I think it will be an attractive option.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2127697, ~/Articles/ArticleHandler.aspx, 10/25/2016 8:24:10 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,169.27 -53.76 -0.30%
S&P 500 2,143.16 -8.17 -0.38%
NASD 5,283.40 -26.43 -0.50%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/25/2016 4:00 PM
AAPL $118.25 Up +0.60 +0.51%
Apple CAPS Rating: ****
BBRY $7.27 Down -0.08 -1.09%
BlackBerry CAPS Rating: *
GOOGL $828.55 Down -7.19 -0.86%
Alphabet (A shares… CAPS Rating: *****
MCPIQ $0.00 Down +0.00 +0.00%
Molycorp, Inc. CAPS Rating: **
NOK $4.97 Down +0.00 +0.00%
Nokia CAPS Rating: **
RCPI $0.00 Down +0.00 +0.00%
Rock Creek Pharmac… CAPS Rating: *
T $36.70 Down -0.16 -0.43%
AT and T CAPS Rating: ****